These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 10435593)

  • 1. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
    Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
    Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RhoA-dependent murine prostate cancer cell proliferation and apoptosis: role of protein kinase Czeta.
    Ghosh PM; Bedolla R; Mikhailova M; Kreisberg JI
    Cancer Res; 2002 May; 62(9):2630-6. PubMed ID: 11980660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geranylgeranylated proteins are involved in the regulation of myeloma cell growth.
    van de Donk NW; Lokhorst HM; Nijhuis EH; Kamphuis MM; Bloem AC
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):429-39. PubMed ID: 15701825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geranylgeranyl diphosphate-based inhibitors of post-translational geranylgeranylation of cellular proteins.
    Macchia M; Jannitti N; Gervasi G; Danesi R
    J Med Chem; 1996 Mar; 39(7):1352-6. PubMed ID: 8691464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling.
    Zhong WB; Liang YC; Wang CY; Chang TC; Lee WS
    Endocr Relat Cancer; 2005 Sep; 12(3):615-29. PubMed ID: 16172195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lovastatin induces apoptosis in malignant mesothelioma cells.
    Rubins JB; Greatens T; Kratzke RA; Tan AT; Polunovsky VA; Bitterman P
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1616-22. PubMed ID: 9603146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells.
    Agarwal B; Bhendwal S; Halmos B; Moss SF; Ramey WG; Holt PR
    Clin Cancer Res; 1999 Aug; 5(8):2223-9. PubMed ID: 10473109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein prenylation: key to ras function and cancer intervention?
    Khosravi-Far R; Cox AD; Kato K; Der CJ
    Cell Growth Differ; 1992 Jul; 3(7):461-9. PubMed ID: 1419908
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of the cholesterol pathway and Ras maturation in response to stress.
    Shack S; Gorospe M; Fawcett TW; Hudgins WR; Holbrook NJ
    Oncogene; 1999 Oct; 18(44):6021-8. PubMed ID: 10557091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors.
    Kusama T; Mukai M; Iwasaki T; Tatsuta M; Matsumoto Y; Akedo H; Nakamura H
    Cancer Res; 2001 Jun; 61(12):4885-91. PubMed ID: 11406567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific labeling of isoprenylated proteins: application to study inhibitors of the post-translational farnesylation and geranylgeranylation.
    Danesi R; McLellan CA; Myers CE
    Biochem Biophys Res Commun; 1995 Jan; 206(2):637-43. PubMed ID: 7826382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
    Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
    Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
    Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
    Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase inhibitor lovastatin causes reversible cytoskeleton perturbation by RhoA signalling suppression in peritoneal cell line Met5A.
    Suzuki N; Imai A
    J Obstet Gynaecol; 2010 May; 30(4):404-7. PubMed ID: 20455727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells.
    Ghosh PM; Mott GE; Ghosh-Choudhury N; Radnik RA; Stapleton ML; Ghidoni JJ; Kreisberg JI
    Biochim Biophys Acta; 1997 Oct; 1359(1):13-24. PubMed ID: 9398081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lovastatin induces apoptosis of spontaneously immortalized rat brain neuroblasts: involvement of nonsterol isoprenoid biosynthesis inhibition.
    García-Román N; Alvarez AM; Toro MJ; Montes A; Lorenzo MJ
    Mol Cell Neurosci; 2001 Feb; 17(2):329-41. PubMed ID: 11178870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin induces apoptosis and cell growth arrest in prostate cancer cells.
    Hoque A; Chen H; Xu XC
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):88-94. PubMed ID: 18199714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lovastatin-induced PC-12 cell differentiation is associated with RhoA/RhoA kinase pathway inactivation.
    Fernández-Hernando C; Suárez Y; Lasunción MA
    Mol Cell Neurosci; 2005 Aug; 29(4):591-602. PubMed ID: 15951198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
    Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
    Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.